Ligand validation:3D8V

UD1: URIDINE-DIPHOSPHATE-N-ACETYLGLUCOSAMINE

UD1 is a Ligand Of Interest in 3D8V designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3D8V_UD1_A_496	57%	40%	0.194	0.969	0.91	1.42	3	8	4	0	100%	1
4G3Q_UD1_A_506	98%	28%	0.059	0.983	1.34	1.53	5	10	0	0	100%	1
4G3P_UD1_A_506	95%	33%	0.08	0.983	1.22	1.41	5	12	0	0	100%	1
3DJ4_UD1_A_4000	72%	27%	0.153	0.979	1.29	1.62	5	9	1	0	100%	1
4G3S_UD1_A_501	70%	40%	0.113	0.93	0.98	1.36	2	6	0	0	100%	1
3SPT_UD1_A_498	60%	41%	0.13	0.915	0.89	1.41	2	7	1	0	100%	1
4R7U_UD1_A_503	99%	29%	0.049	0.98	1.26	1.55	6	11	0	0	100%	1
4FKZ_UD1_A_401	99%	44%	0.056	0.986	0.87	1.3	2	6	2	0	100%	1
7TB0_UD1_A_501	99%	62%	0.064	0.991	0.57	0.89	-	1	0	0	100%	1
4NES_UD1_A_400	98%	22%	0.052	0.977	1.9	1.38	10	6	1	0	100%	1
1HZJ_UD1_A_401	98%	53%	0.066	0.986	0.69	1.13	-	4	0	0	100%	0.9487

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.